Meningioma secondary prevention: Difference between revisions

	Meningioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Meningioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Meningioma secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Meningioma secondary prevention All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Meningioma secondary prevention
CDC on Meningioma secondary prevention
Meningioma secondary prevention in the news
Blogs on Meningioma secondary prevention
Directions to Hospitals Treating Meningioma
Risk calculators and risk factors for Meningioma secondary prevention

Latest revision as of 14:47, 10 September 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]

There are no established measures for the secondary prevention of meningioma.

There are no established measures for the secondary prevention of meningioma.

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Meningioma}}
-{{CMG}}
+{{CMG}} {{AE}} {{IO}} {{HL}}
 ==Overview==
+There are no established measures for the secondary prevention of meningioma.
 ==Secondary Prevention==
-The reasons of developing meningioma are not clear. Epidemiological survey demonstrates the folling measure may be helpful:
+There are no established measures for the secondary prevention of meningioma.
-:*Avoidance over-dosage radiation therapy on head.
-:*Early screening of disorder neurofibromatosis type 2.
 ==References==
-{{reflist|2}}
+{{Reflist|2}}
-[[Category:Disease]]
-[[Category:Types of cancer]]
-[[Category:Neurology]]
-[[Category:Neurosurgery]]
-{{WikiDoc Help Menu}}
+{{WH}}
-{{WikiDoc Sources}}
+{{WS}}
+[[Category: (name of the system)]]